Testing effectiveness (Phase 2)UnknownNCT02758587
What this trial is testing
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
Who this might be right for
Carcinoma, Non-small-cell LungMesotheliomaPancreatic Neoplasms
NHS Greater Glasgow and Clyde 59